Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine vs infliximab maintenance therapy in Crohn's disease remission
2008-001131-35Phase 4Active
- Sponsor
- Academic Medical Center
- Start
- May 2008
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of infliximab and azathioprine in Crohn's disease (3 arms), sponsored by Academic Medical Center. Primary endpoint: Relapse during 12-month follow-up. Started May 2008; status: active.
02
Drugs
infliximabazathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2008-001131-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001131-35.